ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
66.745,20
2,31%
Brent Oil
83,76
0,67%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sunshine Biopharma Inc (SBFM)

  7. Sunshine Biopharma Inc (SBFM) Notícias

SBFM

Sunshine Biopharma (SBFM)

Sunshine Biopharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SBFM
DataHoraFonteTítuloCódigoCompanhia
06/03/202418:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
05/03/202418:37Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SBFMSunshine Biopharma Inc
05/03/202418:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
23/02/202418:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
14/02/202413:18Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SBFMSunshine Biopharma Inc
13/02/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SBFMSunshine Biopharma Inc
09/02/202419:17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SBFMSunshine Biopharma Inc
09/02/202410:59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
01/02/202418:17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SBFMSunshine Biopharma Inc
08/01/202410:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SBFMSunshine Biopharma Inc
04/12/202310:30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMSunshine Biopharma Inc
13/11/202310:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMSunshine Biopharma Inc
19/10/202313:10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SBFMSunshine Biopharma Inc
18/10/202314:32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
25/08/202316:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
11/08/202309:30GlobeNewswire Inc.Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%NASDAQ:SBFMSunshine Biopharma Inc
06/06/202307:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBFMSunshine Biopharma Inc
05/06/202318:29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SBFMSunshine Biopharma Inc
25/05/202317:05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SBFMSunshine Biopharma Inc
17/05/202314:31Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SBFMSunshine Biopharma Inc
16/05/202310:58GlobeNewswire Inc.Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMSunshine Biopharma Inc
12/05/202309:00GlobeNewswire Inc.Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMSunshine Biopharma Inc
11/05/202318:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBFMSunshine Biopharma Inc
11/05/202310:00GlobeNewswire Inc.Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%NASDAQ:SBFMSunshine Biopharma Inc
10/05/202317:05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SBFMSunshine Biopharma Inc
05/04/202309:00GlobeNewswire Inc.Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate UpdateNASDAQ:SBFMSunshine Biopharma Inc
04/04/202307:10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SBFMSunshine Biopharma Inc
28/02/202309:30GlobeNewswire Inc.Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 TreatmentNASDAQ:SBFMSunshine Biopharma Inc
10/02/202309:35GlobeNewswire Inc.Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer CompoundNASDAQ:SBFMSunshine Biopharma Inc
19/01/202309:30GlobeNewswire Inc.Sunshine Biopharma Announces Share Repurchase ProgramNASDAQ:SBFMSunshine Biopharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SBFM

Seu Histórico Recente

KUCN
GLMRUSDT
Moonbeam
LSE
MSR
Mediasurface
BIT
F15706
Vontobel Financial Produ...
ASX
AAP
Australian Agricultural ...
LSE
LND
Landore Resources
COIN
BTCVLEUR
COIN
NJBCBTC
JBCOIN New Japan Brand Coin
LSE
77RG
Investec Bnk 25
COIN
NEXEUR
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados